Immunovant (NASDAQ:IMVT) reported quarterly earnings results on February 06, 2026 that exceeded analyst expectations. The Healthcare company reported earnings per share of $-0.61,…
Immunovant (NASDAQ:IMVT) reported quarterly earnings results on February 06, 2026 that exceeded analyst expectations.
The Healthcare company reported earnings per share of $-0.61, beating the consensus estimate of $-0.71 by $0.10 per share. Revenue came in at , missing the estimate of $2.4M.
Immunovant's stock moved following the earnings release. The stock currently trades at $27.38 with a market capitalization of $4.4B.
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Current market data
NASDAQ · IMVT
$38.75
Down: -$0.65 · -1.68%
Live quote updated
Keep reading
earnings ·
sec_filing ·
analyst ·
institutional ·
